• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫荧光染色在研究受体酪氨酸激酶ErbB家族中的应用。

Application of Immunofluorescence Staining to Study ErbB Family of Receptor Tyrosine Kinases.

作者信息

Nami Babak, Wang Zhixiang

机构信息

Department of Medical Genetics and Signal Transduction Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

出版信息

Methods Mol Biol. 2017;1652:109-116. doi: 10.1007/978-1-4939-7219-7_7.

DOI:10.1007/978-1-4939-7219-7_7
PMID:28791637
Abstract

Immunofluorescence staining is an effective method for visualizing ErbB family of receptor tyrosine kinases and to monitor their expression, phosphorylation, and localization in individual cells. However, immunofluorescence staining for membrane proteins is required preserving integrity of cell membrane intact by protecting the cells from organic solvents. Permeabilization of cells may increase nonspecific intracellular background signal as an inevitable result. This chapter describes procedures for the application of indirect immunofluorescence staining for ErbB receptors in adherent and suspended cells as well as in paraffin-embedded tissue sections.

摘要

免疫荧光染色是一种可视化受体酪氨酸激酶ErbB家族并监测其在单个细胞中的表达、磷酸化和定位的有效方法。然而,对膜蛋白进行免疫荧光染色时,需要通过保护细胞免受有机溶剂的影响来保持细胞膜的完整性。细胞通透处理不可避免地可能会增加非特异性细胞内背景信号。本章介绍了在贴壁细胞、悬浮细胞以及石蜡包埋组织切片中对ErbB受体进行间接免疫荧光染色的操作步骤。

相似文献

1
Application of Immunofluorescence Staining to Study ErbB Family of Receptor Tyrosine Kinases.免疫荧光染色在研究受体酪氨酸激酶ErbB家族中的应用。
Methods Mol Biol. 2017;1652:109-116. doi: 10.1007/978-1-4939-7219-7_7.
2
Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia.人眼表上皮中受体酪氨酸激酶、表皮生长因子受体、ErbB2和ErbB3的表达
Cornea. 2001 Jan;20(1):81-5. doi: 10.1097/00003226-200101000-00016.
3
Localization and modulation of ErbB receptor tyrosine kinases.表皮生长因子受体酪氨酸激酶的定位与调节
Curr Opin Cell Biol. 2001 Apr;13(2):125-30. doi: 10.1016/s0955-0674(00)00188-5.
4
Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.表皮生长因子受体家族配体和受体在胃癌中的表达。
Pathobiology. 2017;84(4):210-217. doi: 10.1159/000464250. Epub 2017 Apr 12.
5
Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma.受体酪氨酸激酶作为脑膜瘤的候选预后生物标志物和治疗靶点。
Int J Mol Sci. 2021 Oct 21;22(21):11352. doi: 10.3390/ijms222111352.
6
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.HER家族mRNA表达在高危早期乳腺癌中的预后意义评估:一项希腊合作肿瘤学组(HeCOG)验证研究
J Transl Med. 2015 May 29;13:171. doi: 10.1186/s12967-015-0530-0.
7
Flow cytometric FRET analysis of ErbB receptor tyrosine kinase interaction.表皮生长因子受体(ErbB)受体酪氨酸激酶相互作用的流式细胞术荧光共振能量转移分析
Curr Protoc Cytom. 2008 Jul;Chapter 12:Unit12.14. doi: 10.1002/0471142956.cy1214s45.
8
Phosphorylation sites of HER2/c-erbB-2: role in cell growth and in disease.HER2/c-erbB-2的磷酸化位点:在细胞生长和疾病中的作用
Acta Biochim Pol. 2014;61(4):699-703. Epub 2014 Nov 14.
9
Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.表皮调节素与表皮生长因子受体和ErbB-4结合,并诱导表皮生长因子受体、ErbB-2、ErbB-3和ErbB-4的酪氨酸磷酸化。
Oncogene. 1997 Dec 4;15(23):2841-8. doi: 10.1038/sj.onc.1201458.
10
Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors.基于放射性核素的常见表达表皮生长因子受体(EGFR)家族受体癌症的临床成像与治疗潜力。
Tumour Biol. 2012 Jun;33(3):653-9. doi: 10.1007/s13277-011-0307-x. Epub 2012 Jan 7.

引用本文的文献

1
A Non-Canonical p75HER2 Signaling Pathway Underlying Trastuzumab Action and Resistance in Breast Cancer.一种非经典的 p75HER2 信号通路,该通路是曲妥珠单抗在乳腺癌中发挥作用和产生耐药性的基础。
Cells. 2024 Aug 29;13(17):1452. doi: 10.3390/cells13171452.
2
Epigenetic Silencing of HER2 Expression during Epithelial-Mesenchymal Transition Leads to Trastuzumab Resistance in Breast Cancer.上皮-间质转化过程中HER2表达的表观遗传沉默导致乳腺癌对曲妥珠单抗耐药。
Life (Basel). 2021 Aug 24;11(9):868. doi: 10.3390/life11090868.
3
The Effects of Pertuzumab and Its Combination with Trastuzumab on HER2 Homodimerization and Phosphorylation.
帕妥珠单抗及其与曲妥珠单抗联合应用对HER2同源二聚化和磷酸化的影响。
Cancers (Basel). 2019 Mar 16;11(3):375. doi: 10.3390/cancers11030375.